Ivím Health
US$ 23.74
tirzepatide clinical trial enrollment on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 Tirzepatide: First Approval | Drugs
Description
When we identify and correct root causes (hormones, gut, nutrients, sleep), fat loss becomes easier and more sustainable
Zepbound (tirzepatide) injection
When combined with lifestyle modifications, such as a balanced diet and regular physical activity, Zepbound has shown promise in helping patients achieve and sustain a healthier weight, which can be a cornerstone in the long-term strategy against obesity related health issues
However, it is not recommended to be taken on an empty stomach
These medications should only be used under the supervision of a licensed healthcare provider
Not just marketing claims
